ESPR Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 123971 min ago

@ $2.49

Wydano: 13 vas. 2024 @ 22:31

Zwrot: -16.06%

Poprzedni sygnał: vas. 12 - 20:36

Poprzedni sygnał: Kupno

Zwrot: -4.41 %

Live Chart Being Loaded With Signals

Commentary (9 geg. 2024 @ 23:00):

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol...

Stats
Dzisiejszy wolumen	7.34M
Średni wolumen	6.95M
Kapitalizacja rynkowa	356.17M
EPS	$0 ( 2024-05-07 )
Następna data zysków	( $-0.170 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.030
ATR14	$0.00700 (0.33%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-14	Warren Eric	Buy	100 000	Common Stock
2024-03-14	Warren Eric	Buy	150 000	Stock Option (right to buy)
2024-03-14	Foody Joanne M.	Buy	150 000	Common Stock
2024-03-14	Foody Joanne M.	Buy	200 000	Stock Option (right to buy)
2024-03-14	Looker Benjamin	Buy	100 000	Common Stock

INSIDER POWER
98.73
Last 98 transactions
Buy: 4 476 078 \| Sell: 52 346

Wolumen Korelacja

Długi: -0.28 (neutral)

Krótki: -0.33 (neutral)

Signal:(45.148) Neutral

Esperion Therapeutics Inc Korelacja

10 Najbardziej pozytywne korelacje
TCPC	0.971
STIM	0.97
BRKL	0.967
RVSB	0.965
CPTN	0.964
IBCP	0.958
HMST	0.958
FNWB	0.956
FRST	0.955
ISTR	0.955

10 Najbardziej negatywne korelacje
ALBO	-0.958
PLPC	-0.957
MOTNU	-0.953
KBAL	-0.951
CMPI	-0.951
HUGE	-0.95
ZGNX	-0.949
ADMS	-0.949
LMB	-0.944
UNCY	-0.943

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Esperion Therapeutics Inc Korelacja - Waluta/Towar

0.32
( neutral )

0.23
( neutral )

0.00
( neutral )

0.61
( weak )

-0.46
( neutral )

Esperion Therapeutics Inc Finanse

Annual	2023
Przychody:	$116.33M
Zysk brutto:	$72.90M (62.67 %)
EPS:	$-2.03

FY	2023
Przychody:	$116.33M
Zysk brutto:	$72.90M (62.67 %)
EPS:	$-2.03

FY	2022
Przychody:	$75.48M
Zysk brutto:	$48.51M (64.27 %)
EPS:	$-4.33

FY	2021
Przychody:	$78.45M
Zysk brutto:	$64.23M (81.88 %)
EPS:	$-10.17

Financial Reports:

No articles found.

Esperion Therapeutics Inc

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

Aktualne aktualizacje dla Esperion Therapeutics Inc [ESPR]

Upcoming Earnings Alert